A deep learning model using echocardiography accurately detects cardiac amyloidosis, outperforming traditional methods.
Key Details
- 1AI model trained on echocardiography video clips from 2,612 patients across multiple sites and ethnic groups.
- 2External validation performed on 18 global sites; included 597 amyloidosis cases and 2,122 controls.
- 3Achieved AUROC of 0.93 (after excluding 13% uncertain predictions), sensitivity of 85%, specificity of 93%.
- 4Performance was consistent across amyloidosis subtypes and various subgroups.
- 5The AI model outperformed transthyretin cardiac amyloidosis (TTR-CA) score (AUROC = 0.73) and wall thickness scoring (AUROC = 0.8).
- 6Ultromics employees contributed and funded the study.
Why It Matters
This work demonstrates the robust, generalizable performance of AI to enhance echocardiographic detection of cardiac amyloidosis, surpassing current clinical scoring tools and suggesting real-world impact for earlier and more accurate diagnosis in routine practice.
Source
AuntMinnie
Related News
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•AuntMinnie
AI Models Reveal Racial Disparities in Breast Cancer Patterns
Machine learning models reveal significant racial disparities and key predictors in breast cancer incidence across diverse groups.
•AuntMinnie
AI Algorithm Streamlines and Standardizes Shoulder Ultrasound Acquisition
A multitask AI system demonstrated high accuracy in standardizing and guiding shoulder musculoskeletal ultrasound imaging.